Current challenges in contraception in adolescents and young women

医学 计划生育 药丸 发达国家 意外怀孕 妇科 激素避孕 地塞米松 产科 左炔诺孕酮 人口 环境卫生 研究方法 护理部
作者
Ariana Cornet
出处
期刊:Current Opinion in Obstetrics & Gynecology [Ovid Technologies (Wolters Kluwer)]
卷期号:25 (Supplement 1): S1-S10 被引量:12
标识
DOI:10.1097/gco.0b013e32835e06fd
摘要

Purpose of review Although developing countries have made much progress in expanding the availability and use of family planning services, the need for effective contraception is large, and growing because the largest cohorts in human history are entering their reproductive years. Not only regarding developing countries but also in developed countries, where the usual contraceptive methods, such as the oral contraceptives, intrauterine devices (IUDs) and condoms, have been available for decades, there have been many new advances in contraceptive technology in the last several years. New formulations of oral contraceptives, extended and continuous use of oral contraceptives and long-acting reversible contraceptives (LARC) may have a wider role in contraception and their increased implementation could help to reduce unintended pregnancy. Recent findings Today's oral contraceptive regimens are safer and more tolerable, with equal or improved efficacy as compared to early formulations. Incremental decreases in the estrogen dosage have helped to alleviate some of the unwanted estrogenic side effects of combined hormonal contraceptives. Progestogens have also been controversial in connection with findings of increased venous thromboembolism risks but they have evolved over time, and, in general, newer generations of progestins have minimal side effects. Currently available 'LARC' methods, such as IUDs, the intrauterine system, injectable contraceptives and implants require administration less than once per cycle or month. They are more cost effective than the combined oral contraceptive pill even at 1 year of use. Increasing the access and availability of new formulations of oral contraceptives and LARC methods will reduce the number of unintended pregnancies. Summary Evidence-based guidelines about the safety of contraceptive methods among women with comorbid medical conditions can help guide providers in determining the best method of contraception for each woman, depending on whether they are in their adolescent, postpartum or perimenopause years. As most patients can safely use highly effective methods of contraception, health providers should promote their use in order to further efforts to reduce unintended pregnancy. This promotion should be done by enabling women to make an informed choice among all contraceptive options.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
朱zhu发布了新的文献求助10
1秒前
1秒前
顾矜应助healthy采纳,获得10
1秒前
大林发布了新的文献求助10
3秒前
4秒前
5秒前
别介完成签到,获得积分10
7秒前
ajin完成签到,获得积分10
7秒前
8秒前
英姑应助朱zhu采纳,获得10
9秒前
hoho发布了新的文献求助30
9秒前
科研柠檬精酸酸完成签到,获得积分10
9秒前
河马发布了新的文献求助10
10秒前
FXT完成签到 ,获得积分10
10秒前
August完成签到,获得积分10
11秒前
清脆金鱼完成签到,获得积分10
12秒前
Yaoz发布了新的文献求助10
15秒前
15秒前
16秒前
脑洞疼应助ludy采纳,获得10
18秒前
no1isme完成签到 ,获得积分10
18秒前
hokuto应助虚幻的又蓝采纳,获得10
19秒前
21秒前
0409hhh完成签到 ,获得积分10
21秒前
Li发布了新的文献求助10
21秒前
DYN发布了新的文献求助30
22秒前
hyq008发布了新的文献求助20
24秒前
李健应助洁净行云采纳,获得10
25秒前
25秒前
25秒前
小蘑菇应助春生采纳,获得10
26秒前
26秒前
26秒前
yangjoy完成签到 ,获得积分10
26秒前
慕青应助郝宝真采纳,获得10
27秒前
搜集达人应助hoho采纳,获得10
28秒前
29秒前
Burnell发布了新的文献求助10
29秒前
一拳一个小欧阳完成签到 ,获得积分10
30秒前
大糖糕僧发布了新的文献求助10
30秒前
高分求助中
Evolution 10000
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
юрские динозавры восточного забайкалья 800
English Wealden Fossils 700
Foreign Policy of the French Second Empire: A Bibliography 500
Chen Hansheng: China’s Last Romantic Revolutionary 500
China's Relations With Japan 1945-83: The Role of Liao Chengzhi 400
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3147962
求助须知:如何正确求助?哪些是违规求助? 2798966
关于积分的说明 7832977
捐赠科研通 2456063
什么是DOI,文献DOI怎么找? 1307113
科研通“疑难数据库(出版商)”最低求助积分说明 628062
版权声明 601620